Trials / Conditions / Agnogenic Myeloid Metaplasia
Agnogenic Myeloid Metaplasia
5 registered clinical trials studyying Agnogenic Myeloid Metaplasia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People NCT07362225 | MPN Research Foundation | — |
| Completed | A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies NCT00506402 | CASI Pharmaceuticals, Inc. | Phase 1 |
| Completed | Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) NCT00255346 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP NCT00088231 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) NCT00136409 | Dana-Farber Cancer Institute | Phase 2 |